Syremis Therapeutics

Manufacturing · Israel · 11-50 Employees

View Company Info for Free

Overview

Headquarters

17 Yigiah Kapayim St, Petah Tiqwa, Centr...

Revenue

$5.7 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1

About Syremis Therapeutics

Syremis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health. The company’s neuropsychiatric pipeline is rooted in emerging and clinically validated mechanisms, including muscarinic M1/M4 agonism and next-generation NMDA antagonism.Explore more
Syremis Therapeutics's Social MediaPopular SearchesSyremis TherapeuticsSIC Code 28,283NAICS Code 32,325Show more

Syremis Therapeutics Org Chart

PhoneEmail
Menashe Levy, Co-founder & Chief Technology Officer at Syremis Therapeutics
Israel flag for contact location.

Co-founder & Chief Technology Officer

PhoneEmail
Eli Gendler, Chief Financial Officer at Syremis Therapeutics
Israel flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
AF
Israel flag for contact location.

Head of Chemistry

PhoneEmail
MG
Israel flag for contact location.

Qp Head of QA

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Syremis Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Syremis Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Syremis Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Syremis Therapeutics.

Syremis Therapeutics financials insights

Gather financial insights about Syremis Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2025

Series A

$165M

See All Syremis Therapeutics's Financials Insights

Top Manufacturing Companies

Frequently Asked Questions Regarding Syremis Therapeutics

What is Syremis Therapeutics's official website?
Syremis Therapeutics's official website is www.syremis.com
What is Syremis Therapeutics's Revenue?
Syremis Therapeutics's revenue is $5.7 Million
What is Syremis Therapeutics's SIC code?
Syremis Therapeutics's SIC: 28,283
What is Syremis Therapeutics's NAICS code?
Syremis Therapeutics's NAICS: 32,325
How many employees does Syremis Therapeutics have?
Syremis Therapeutics has 11-50 employees
What industry does Syremis Therapeutics belong to?
Syremis Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
Who is the CFO of Syremis Therapeutics?
Syremis Therapeutics's CFO is Eli Gendler
Who is the CTO of Syremis Therapeutics?
Syremis Therapeutics's CTO is Menashe Levy
What does Syremis Therapeutics do?

Syremis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health. The company’s neuropsychiatric pipeline is rooted in emerging and clinically validated mechanisms, including muscarinic M1/M4 agonism and next-generation NMDA antagonism.... Read More

What are Syremis Therapeutics social media links?
Syremis Therapeutics Linkedin page
Who invested in Syremis Therapeutics?
Syremis Therapeutics has 4 investors including Dexcel Pharma, Bain Capital, Third Rock Ventures and GV.
Is Syremis Therapeutics a public company?
Syremis Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Syremis Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.